Related Experiment Video
Updated: Jul 15, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
High throughput functional analysis of HIV-1 env genes without cloning
Jennifer L Kirchherr1, Xiaozhi Lu, Webster Kasongo
1Duke Human Vaccine Institute and Center for HIV-AIDS Vaccine Immunology, Department of Medicine, Duke University Medical Center, 112 RPIII, Research Drive, Box 3347, Durham, NC 27710, USA.
A new promoter PCR (pPCR) method rapidly characterizes functional human immunodeficiency virus type 1 (HIV-1) env genes. This high-throughput approach streamlines vaccine design and pathogenesis studies by eliminating laborious cloning steps.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Functional human immunodeficiency virus type 1 (HIV-1) env genes are crucial for vaccine design, neutralization assays, and pathogenesis research.
- Traditional methods for obtaining functional env clones are time-consuming and labor-intensive.
Purpose of the Study:
- To develop a high-throughput method for characterizing HIV-1 env genes.
- To streamline the generation of pseudovirions for functional analysis.
Main Methods:
- A novel promoter PCR (pPCR) method was developed, linking rev/env gene cassettes with the cytomegalovirus (CMV) promoter using overlapping PCR.
- Pseudovirions were generated by cotransfecting pPCR products and a pSG3 Delta env backbone into 293T cells.
- Functional analysis was performed by infecting TZM-bl cells.
Main Results:
- The pPCR method successfully generated functional pseudovirions from 86% of tested rev/env gene cassettes.
- Pseudoviruses produced via pPCR exhibited similar neutralization sensitivity to patient sera and monoclonal antibodies compared to those from plasmid DNA.
- The method yields sufficient pseudovirions for extensive neutralization assays.
Conclusions:
- The pPCR method offers a rapid, high-throughput alternative for analyzing multiple HIV-1 env genes.
- This technique bypasses traditional cloning, transformation, and plasmid DNA preparation, accelerating research in HIV-1 vaccine development and pathogenesis.
More Related Videos
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018